[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Moderna Inc (MRNA)

Moderna Inc (MRNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 31,647,652
  • Shares Outstanding, K 396,786
  • Annual Sales, $ 1,944 M
  • Annual Income, $ -2,822 M
  • EBIT $ -3,412 M
  • EBITDA $ -3,264 M
  • 60-Month Beta 0.94
  • Price/Sales 14.80
  • Price/Cash Flow N/A
  • Price/Book 4.27

Options Overview Details

View History
  • Implied Volatility 97.24% (+5.67%)
  • Historical Volatility 74.37%
  • IV Percentile 99%
  • IV Rank 87.65%
  • IV High 103.33% on 11/03/25
  • IV Low 54.03% on 08/06/25
  • Expected Move (DTE 5) 7.20 (9.03%)
  • Put/Call Vol Ratio 0.22
  • Today's Volume 120,951
  • Volume Avg (30-Day) 60,886
  • Put/Call OI Ratio 0.89
  • Today's Open Interest 592,650
  • Open Int (30-Day) 633,306
  • Expected Range 72.56 to 86.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 24 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-2.00
  • Number of Estimates 9
  • High Estimate $-1.32
  • Low Estimate $-2.35
  • Prior Year $-2.13
  • Growth Rate Est. (year over year) +6.10%

Price Performance

See More
Period Period Low Period High Performance
1-Month
45.30 +76.07%
on 06/03/26
81.40 -2.01%
on 07/02/26
+34.12 (+74.76%)
since 06/02/26
3-Month
43.68 +82.60%
on 05/01/26
81.40 -2.01%
on 07/02/26
+30.56 (+62.11%)
since 04/02/26
52-Week
22.28 +257.99%
on 11/21/25
81.40 -2.01%
on 07/02/26
+49.48 (+163.41%)
since 07/02/25

Most Recent Stories

More News
MarketBeat Week in Review – 06/29 - 07/03

MarketBeat's weekly roundup covers a weaker June jobs report, tech sector rotation, and top analyst picks including TSLA, AVGO, PLTR, MRNA, and NEE heading into Q2 earnings season.

NFLX : 77.65 (+4.66%)
META : 582.90 (-4.90%)
AVGO : 360.45 (-2.41%)
SNDK : 1,745.00 (-14.13%)
RKLB : 100.46 (+0.39%)
MDA : 40.75 (+3.16%)
NEE : 88.34 (+2.28%)
HSY : 182.14 (+1.94%)
QSR : 74.79 (+4.66%)
COST : 951.67 (+2.92%)
TSLA : 393.45 (-7.49%)
SPCX : 162.00 (+2.83%)
3 Cash-Heavy Stocks with Warning Signs

3 Cash-Heavy Stocks with Warning Signs

FVRR : 10.81 (-0.92%)
PEGA : 31.05 (-0.14%)
MRNA : 79.76 (+10.01%)
Trump’s Newly Disclosed Moderna Trades Preceded FDA Advisory Panel’s Unanimous Backing of mRNA Flu Vaccine

President Donald Trump’s stock transaction filings reveal multiple purchases of Moderna ($MRNA) during March 2026, followed by a partial sale on May 18. Since those trades, the FDA's Vaccines and Related...

MRNA : 79.76 (+10.01%)
PFE : 24.32 (+1.84%)
GSK : 53.66 (+4.60%)
Short Squeeze Alert—Moderna Stock Surges on New Strategy

Moderna shares rose nearly 20% after Science Day, driven partly by a short squeeze, while its mRNA pipeline beyond vaccines faces a multi-year path to revenue.

MRNA : 79.76 (+10.01%)
MRNA Stock Spikes as Moderna Shares mRNA Pipeline Update

Moderna stock soars on positive updates during the Science Day presentation. Jefferies sees significant further upside in MRNA shares.

MRNA : 79.76 (+10.01%)
3 Mid-Cap Stocks Walking a Fine Line

3 Mid-Cap Stocks Walking a Fine Line

BEN : 34.11 (+0.15%)
CHTR : 137.20 (-1.89%)
MRNA : 79.76 (+10.01%)
Moderna Science Day Highlights Expanding Potential of mRNA Platform

Provides broad overview of Company's research and early development programs expected to continue to fuel future growth

MRNA : 79.76 (+10.01%)
Intel Stock and 3 Other Winners I Found Using Barchart’s High-Octane Stock Screener

One feature within the Barchart Stock Screener tool that resonated with me is a pre-built filter known as the J-Pattern or J-Curve.

INTC : 120.35 (-5.25%)
RYTM : 114.17 (+3.41%)
$SPX : 7,483.24 (unch)
GEV : 1,113.11 (-1.87%)
MRNA : 79.76 (+10.01%)
FDA panel backs first-of-its-kind flu vaccine using mRNA technology

A new kind of flu vaccine is moving a step closer to the U.S. market

MRNA : 79.76 (+10.01%)
Moderna Announces FDA Advisory Committee Votes Unanimously in Favor of the Benefit-Risk Profile of mRNA-1010, an Investigational Seasonal Influenza Vaccine

FDA Prescription Drug User Fee Act (PDUFA) goal date remains August 5, 2026

MRNA : 79.76 (+10.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 80%. The market has entered extreme overbought territory.

See More Share

Business Summary

Moderna, Inc. is a clinical-stage pharmaceutical company, primarily focused on discovering and developing messenger RNA (mRNA) based therapies. The company's mRNA based COVID-19 vaccine, Spikevax (mRNA-1273), is approved for use in adults in the United States. The vaccine is also authorized for emergency...

See More

Key Turning Points

3rd Resistance Point 90.60
2nd Resistance Point 86.00
1st Resistance Point 82.88
Last Price 79.76
1st Support Level 75.16
2nd Support Level 70.56
3rd Support Level 67.44

See More

52-Week High 81.40
Last Price 79.76
Fibonacci 61.8% 58.82
Fibonacci 50% 51.84
Fibonacci 38.2% 44.86
52-Week Low 22.28

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.